Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
Is a |
Pramoxine hydrochloride |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
Is a |
Clioquinol-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
Is a |
Hydrocortisone-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
Is a |
Product containing hydrocortisone in otic dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Local anti-infective |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Skin antifungal agent |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Pramocaine hydrochloride (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Clioquinol |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
Is a |
Clioquinol + hydrocortisone + pramoxine hydrochloride |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent cutané |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrocortisone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Quinoline and hydroxyquinoline - chemical |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone agent |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydroxychloroquine (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Local anti-infective |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent cutané |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
Has manufactured dose form |
forme pharmaceutique pour usage transdermique et/ou cutané |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
Is a |
Product containing clioquinol in topical dosage form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|